Literature DB >> 26102369

Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.

Emilia Caselli1, Chiara Romagnoli1, Roza Vahabi1, Magdalena A Taracila2, Robert A Bonomo3,2, Fabio Prati1.   

Abstract

Boronic acid transition-state inhibitors (BATSIs) represent one of the most promising classes of β-lactamase inhibitors. Here we describe a new class of BATSIs, namely, n class="Chemical">1-amido-2-triazolylethaneboronic acids, which were synthesized by combining the asymmetric homologation of boronates with copper-catalyzed azide-alkyne cycloaddition for the stereoselective insertion of the amido group and the regioselective formation of the 1,4-disubstituted triazole, respectively. This synthetic pathway, which avoids intermediate purifications, proved to be flexible and efficient, affording in good yields a panel of 14 BATSIs bearing three different R1 amide side chains (acetamido, benzylamido, and 2-thienylacetamido) and several R substituents on the triazole. This small library was tested against two clinically relevant class C β-lactamases from Enterobacter spp. and Pseudomonas aeruginosa. The K(i) value of the best compound (13a) was as low as 4 nM with significant reduction of bacterial resistance to the combination of cefotaxime/13a.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26102369      PMCID: PMC5744665          DOI: 10.1021/acs.jmedchem.5b00341

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  42 in total

1.  NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities.

Authors:  Hugo E. Gottlieb; Vadim Kotlyar; Abraham Nudelman
Journal:  J Org Chem       Date:  1997-10-17       Impact factor: 4.354

2.  Inhibitors of HIV-1 protease by using in situ click chemistry.

Authors:  Matthew Whiting; John Muldoon; Ying-Chuan Lin; Steven M Silverman; William Lindstrom; Arthur J Olson; Hartmuth C Kolb; M G Finn; K Barry Sharpless; John H Elder; Valery V Fokin
Journal:  Angew Chem Int Ed Engl       Date:  2006-02-20       Impact factor: 15.336

3.  Focusing on boron in medicinal chemistry.

Authors:  P Veeraraghavan Ramachandran
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

Review 4.  Confronting the challenges of discovery of novel antibacterial agents.

Authors:  Sheo B Singh
Journal:  Bioorg Med Chem Lett       Date:  2014-06-26       Impact factor: 2.823

Review 5.  The impact of click chemistry in medicinal chemistry.

Authors:  Jingli Hou; Xifang Liu; Jie Shen; Guilong Zhao; Peng George Wang
Journal:  Expert Opin Drug Discov       Date:  2012-05-19       Impact factor: 6.098

6.  Amino acid substitutions at Ambler position Gly238 in the SHV-1 beta-lactamase: exploring sequence requirements for resistance to penicillins and cephalosporins.

Authors:  Andrea M Hujer; Kristine M Hujer; Marion S Helfand; Vernon E Anderson; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as β-lactamase inhibitors.

Authors:  Oliv Eidam; Chiara Romagnoli; Emilia Caselli; Kerim Babaoglu; Denise Teotico Pohlhaus; Joel Karpiak; Richard Bonnet; Brian K Shoichet; Fabio Prati
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

8.  Synthesis of 1,2,3-triazol-1-yl-methaneboronic acids via click chemistry: an easy access to a new potential scaffold for protease inhibitors.

Authors:  Chiara Romagnoli; Emilia Caselli; Fabio Prati
Journal:  European J Org Chem       Date:  2015-02-01

9.  Nanomolar inhibitors of AmpC beta-lactamase.

Authors:  Federica Morandi; Emilia Caselli; Stefania Morandi; Pamela J Focia; Jesús Blázquez; Brian K Shoichet; Fabio Prati
Journal:  J Am Chem Soc       Date:  2003-01-22       Impact factor: 15.419

10.  Effect of an amino acid insertion into the omega loop region of a class C beta-lactamase on its substrate specificity.

Authors:  M Nukaga; K Taniguchi; Y Washio; T Sawai
Journal:  Biochemistry       Date:  1998-07-21       Impact factor: 3.162

View more
  9 in total

1.  Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors.

Authors:  Emilia Caselli; Chiara Romagnoli; Rachel A Powers; Magdalena A Taracila; Alexandra A Bouza; Hollister C Swanson; Kali A Smolen; Francesco Fini; Bradley J Wallar; Robert A Bonomo; Fabio Prati
Journal:  ACS Infect Dis       Date:  2017-12-08       Impact factor: 5.084

2.  Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design.

Authors:  Laura J Rojas; Magdalena A Taracila; Krisztina M Papp-Wallace; Christopher R Bethel; Emilia Caselli; Chiara Romagnoli; Marisa L Winkler; Brad Spellberg; Fabio Prati; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

3.  α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs.

Authors:  Maria Luisa Introvigne; Magdalena A Taracila; Fabio Prati; Emilia Caselli; Robert A Bonomo
Journal:  ChemMedChem       Date:  2020-06-22       Impact factor: 3.466

4.  1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase.

Authors:  Emilia Caselli; Francesco Fini; Maria Luisa Introvigne; Mattia Stucchi; Magdalena A Taracila; Erin R Fish; Kali A Smolen; Philip N Rather; Rachel A Powers; Bradley J Wallar; Robert A Bonomo; Fabio Prati
Journal:  ACS Infect Dis       Date:  2020-06-24       Impact factor: 5.084

5.  Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.

Authors:  Melissa D Barnes; Magdalena A Taracila; Joseph D Rutter; Christopher R Bethel; Ioannis Galdadas; Andrea M Hujer; Emilia Caselli; Fabio Prati; John P Dekker; Krisztina M Papp-Wallace; Shozeb Haider; Robert A Bonomo
Journal:  mBio       Date:  2018-12-11       Impact factor: 7.867

6.  Transition-metal free C-C bond cleavage/borylation of cycloketone oxime esters.

Authors:  Jin-Jiang Zhang; Xin-Hua Duan; Yong Wu; Jun-Cheng Yang; Li-Na Guo
Journal:  Chem Sci       Date:  2018-10-02       Impact factor: 9.825

7.  Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor.

Authors:  Tatsuya Ishikawa; Nayuta Furukawa; Emilia Caselli; Fabio Prati; Magdalena A Taracila; Christopher R Bethel; Yoshikazu Ishii; Akiko Shimizu-Ibuka; Robert A Bonomo
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

8.  Synthesis of vinyl-1,2,3-triazole derivatives under transition metal-free conditions.

Authors:  Menghan Cui; Changhui Su; Rong Wang; Qing Yang; Chunxiang Kuang
Journal:  RSC Adv       Date:  2021-12-06       Impact factor: 4.036

Review 9.  Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications.

Authors:  Mariana Pereira Silva; Lucília Saraiva; Madalena Pinto; Maria Emília Sousa
Journal:  Molecules       Date:  2020-09-21       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.